VOYA Investment Management
ADMS

VOYA Investment Management’s Adamas Pharmaceuticals ADMS Stock Holding History

VOYA Investment Management’s Portfolio ADMS Stock Details ADMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-40,980
Closed -$118K – 2677
2020
Q1 		$118K Buy
40,980
+28,633
+232% +$128K ﹤0.01% 2303
2019
Q4 		$47K Buy
+12,347
New +$59.1K ﹤0.01% 2647
2018
Q3 		– Sell
-8,666
Closed -$224K – 2614
2018
Q2 		$224K Buy
+8,666
New +$240K ﹤0.01% 2314
2018
Q1 		– Sell
-7,070
Closed -$240K – 2597
2017
Q4 		$240K Buy
+7,070
New +$197K ﹤0.01% 2253

Other funds holding ADMS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $3.16B AUM 109.58% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.06B AUM 106.87% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VOYA Investment Management's ADMS Position: Q2 2020 in Review

VOYA Investment Management sold out of Adamas Pharmaceuticals (ADMS) in Q2 2020, closing a stake of 40,980 shares — an estimated $118K sold.

VOYA Investment Management first reported a position in ADMS in Q4 2017 and held it in 4 quarters. The position peaked at $240K in Q4 2017. 61 funds tracked by Wall St. Rank hold ADMS as of Q2 2020.

  • VOYA Investment Management reported no remaining Adamas Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • VOYA Investment Management sold 40,980 Adamas Pharmaceuticals shares in Q2 2020, an estimated $118K.
  • VOYA Investment Management first reported a position in Adamas Pharmaceuticals in Q4 2017 and held it in 4 quarters.
  • VOYA Investment Management's Adamas Pharmaceuticals position peaked at $240K in Q4 2017.
  • 61 funds tracked by Wall St. Rank held Adamas Pharmaceuticals as of Q2 2020.

Based on VOYA Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.